AN2 Therapeutics Statistics
NASDAQ: ANTXHealthcareBiotechnologyUSD
4.85-0.22 (-4.34%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
AN2 Therapeutics by the numbers
AN2 Therapeutics has a market capitalization of $183.0 million based on 37.74M shares outstanding. With trailing EPS of $-1.00, AN2 Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 12.4% below its 50-day average and 27.0% above its 200-day average.
Average daily trading volume is 237.78K shares, or about $1.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ANTX valuation vs. peer median
| Metric | ANTX | Peer median | Difference |
|---|---|---|---|
| Market cap | $183.02M | $182.74M | +0% |
| Avg. volume | 237.78K | 332.92K | -29% |
Peer median across 8 companies: CMPX, ORMP, CNTN, NGEN, ADAG, YARW, DTIL, WHWK.
Valuation
- Market cap
- $183.02M
- EPS (TTM)
- $-1.00
- Shares outstanding
- 37.74M
Price and trading
- Previous close
- 5.07
- Open
- 5.02
- Day range
- 4.70 – 5.06
- 52-week range
- 1.00 – 7.19
- 52-week change
- +270.23%
- Beta
- —
- Volume
- 365.10K
- Average volume
- 237.78K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 14, 2025
Additional statistics
- Market Cap
- 183.02M
- Forward Pe
- -6.06
- Eps
- -1.00
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 7.19
- Week52 Low
- 1.00
- Avg Volume
- 237.78K
- Shares Outstanding
- 37.74M
- Ma50
- 5.54
- Ma200
- 3.82
- Earnings Date
- Aug 14, 2025
- Pct From52w High
- -32.55%
- Pct From52w Low
- 385.00%